IPO Update | Shenzhen Forms Syntron Information (300468.SZ) and Zhenqu Technology's Planned Hong Kong IPO Applications Accepted by China Securities Regulatory Commission

Stock News

01/20

Recently, the China Securities Regulatory Commission (CSRC) released its filing status table for domestic companies seeking overseas securities issuance and listing (covering initial public offerings and full circulation) as of January 16, 2026. Among the updates, the IPO application materials for Shenzhen Forms Syntron Information Co.,Ltd. (300468.SZ) and Zhenqu Technology's planned Hong Kong listing have been accepted by the CSRC. Separately, the filing status for Jingze Biotech's intended Hong Kong IPO is listed as requiring supplementary materials. Furthermore, the application for a full share circulation by L&L Biopharma-B (09887) has been received by the regulator. The full circulation filing for Lingbao Gold (03330) currently holds a status of awaiting additional materials.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1191764202"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1191764202\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1191764202?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-20 14:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1191764202","market":"hk","top_or_hot":-1,"title":"IPO Update | Shenzhen Forms Syntron Information (300468.SZ) and Zhenqu Technology's Planned Hong Kong IPO Applications Accepted by China Securities Regulatory Commission","media":"Stock News","content":"<p>Recently, the China Securities Regulatory Commission (CSRC) released its filing status table for domestic companies seeking overseas securities issuance and listing (covering initial public offerings and full circulation) as of January 16, 2026. Among the updates, the IPO application materials for Shenzhen Forms Syntron Information Co.,Ltd. (300468.SZ) and Zhenqu Technology's planned Hong Kong listing have been accepted by the CSRC. Separately, the filing status for Jingze Biotech's intended Hong Kong IPO is listed as requiring supplementary materials. Furthermore, the application for a full share circulation by L&L Biopharma-B (09887) has been received by the regulator. The full circulation filing for Lingbao Gold (03330) currently holds a status of awaiting additional materials.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IPO Update | Shenzhen Forms Syntron Information (300468.SZ) and Zhenqu Technology's Planned Hong Kong IPO Applications Accepted by China Securities Regulatory Commission</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIPO Update | Shenzhen Forms Syntron Information (300468.SZ) and Zhenqu Technology's Planned Hong Kong IPO Applications Accepted by China Securities Regulatory Commission\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-01-20 14:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Recently, the China Securities Regulatory Commission (CSRC) released its filing status table for domestic companies seeking overseas securities issuance and listing (covering initial public offerings and full circulation) as of January 16, 2026. Among the updates, the IPO application materials for Shenzhen Forms Syntron Information Co.,Ltd. (300468.SZ) and Zhenqu Technology's planned Hong Kong listing have been accepted by the CSRC. Separately, the filing status for Jingze Biotech's intended Hong Kong IPO is listed as requiring supplementary materials. Furthermore, the application for a full share circulation by L&L Biopharma-B (09887) has been received by the regulator. The full circulation filing for Lingbao Gold (03330) currently holds a status of awaiting additional materials.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0142","symbol_name":"区块链","start_time":0,"source_url":"","article_id":"1191764202","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1191764202","pubTimestamp":1768891825,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Recently, the China Securities Regulatory Commission (CSRC) released its filing status table for domestic companies seeking overseas securities issuance and listing (covering initial public offerings...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300468":"四方精创","BK0142":"区块链","BK0231":"软件信息"},"translate_title":"IPO动态|深圳形成合创信息（300468.SZ）、臻趣科技拟赴港IPO申请获证监会受理","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"91341":0.95,"300468":1},"content_text":"Recently, the China Securities Regulatory Commission (CSRC) released its filing status table for domestic companies seeking overseas securities issuance and listing (covering initial public offerings and full circulation) as of January 16, 2026. Among the updates, the IPO application materials for Shenzhen Forms Syntron Information Co.,Ltd. (300468.SZ) and Zhenqu Technology's planned Hong Kong listing have been accepted by the CSRC. Separately, the filing status for Jingze Biotech's intended Hong Kong IPO is listed as requiring supplementary materials. Furthermore, the application for a full share circulation by L&L Biopharma-B (09887) has been received by the regulator. The full circulation filing for Lingbao Gold (03330) currently holds a status of awaiting additional materials.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}